News & Updates

You are invited to attend a complimentary session on Applying Practical Strategies for the Treatment and Management of Patients with CLL.

OFD and DI 2022 take place on Saturday, October 22 and Sunday October 23, 2022 as a two day CCCEP accredited online learning event. Register now!

Have you ever done research and thought about publishing it but didn’t know how to get started?

Join us for a conversation about self leadership in pharmacy with Maria Anwar.

CAPhO Connections Podcast Series keeps the oncology pharmacy community informed on matters affecting you and updated on CAPhO’s news related to education, awards, advocacy and research. Whether it’s your morning commute to work, a walk in the park

Viatris Inc. announced that Abevmy® is now available in Canada. Abevmy, is a biosimilar to Roche’s Avastin® (bevacizumab) and has been authorized for use by Health Canada across four oncology indications.

Many pharmacist-led and CAPhO-supported research initiatives are contributing significantly to advancing cancer care in Canada.

A needs assessment on the management of chronic lymphocytic leukemia (CLL) developed by a multidisciplinary committee of fellow healthcare providers is available!

Can you identify hazardous drug contamination in less than 10 minutes? BD® HD Check is an easy-to-use system to protect your facility from the risk of hazardous drug exposure.

Apotex is proud to be delivering important savings to the Canadian Healthcare System, and to patients with Multiple Myeloma and Myelodysplastic Syndrome, with our MADE IN CANADA lenalidomide product.

The purpose of this study is to gain a better understanding of the febrile neutropenia treatment protocols used across Canada for adult patients receiving chemotherapy for solid organ cancers.

CAPhO members are invited to attend the Charting New Directions in the Treatment and Management of Chronic Lymphocytic Leukemia session hosted by AstraZeneca.